title: Native lung complications after single lung transplantation for emphysema.
abstract: We reviewed the impact of the presence of the native diseased contralateral lung on the outcome after single lung transplantation for emphysema. Twenty consecutive recipients of single lung transplants for emphysema were reviewed for complications related to the native lung. Five patients (25%) suffered major complications arising in the native lung and resulting in serious morbidity and mortality. The timing of onset varied from 1 day to 43 months after transplantation. We conclude that the susceptibility of the native lung to complications such as those described in this report is an additional fact to be considered in choosing the ideal transplant procedure for patients with obstructive lung disease.
authors.affiliation: Division of Cardiovascular and Thoracic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: G
authors.initials: G
authors.lastname: Speziali
authors.forename: J C
authors.initials: JC
authors.lastname: McDougall
authors.forename: D E
authors.initials: DE
authors.lastname: Midthun
authors.forename: S G
authors.initials: SG
authors.lastname: Peters
authors.forename: J P
authors.initials: JP
authors.lastname: Scott
authors.forename: R C
authors.initials: RC
authors.lastname: Daly
authors.forename: C G
authors.initials: CG
authors.lastname: McGregor
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000453:epidemiology; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology; D004646:Emphysema / Q000601:surgery*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008168:Lung / Q000503:physiopathology*; D008171:Lung Diseases / Q000453:epidemiology* / Q000401:mortality; D008175:Lung Neoplasms / Q000453:epidemiology; D016040:Lung Transplantation / Q000009:adverse effects* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011552:Pseudomonas Infections / Q000453:epidemiology; D015996:Survival Rate
chemical_list: D007166:Immunosuppressive Agents